Modernization of Cosmetics Regulation Act
|This whitepaper outlines the shift in cosmetics oversight by the U.S. FDA.
Home » Whitepaper
By ClinChoice
This whitepaper outlines the shift in cosmetics oversight by the U.S. FDA.
By ClinChoice
This paper provides changes and updates to Clinical Trials Regulation in the EU as of December 2023.
By ClinChoice
This whitepaper outlines safety requirements and key considerations in exposure assessments, hazard identification and risk assessments for e-cigarettes in the EU.
By ClinChoice
This whitepaper outlines safety and risk assessments as well as literature monitoring for e-cigarettes in the US.
By ClinChoice
This paper describes the evolution of data standards and recommends best practices in planning and preparing FDA submission packages.
By ClinChoice
This whitepaper describes the role of pharmacovigilance in our modern world and the need for evolution in drug safety data collection.
By ClinChoice
This whitepaper examines the characteristics of various FSP models and how they help bring new therapies to market faster and cost-effectively.
By ClinChoice
This review explores questions and considerations around custom-made, adaptable, and patient-matched medical devices.
Privacy settings
Privacy Settings
This site uses functional cookies and external scripts to improve your experience. Which cookies and scripts are used and how they impact your visit is specified on the left. You may change your settings at any time. Your choices will not impact your visit.
NOTE: These settings will only apply to the browser and device you are currently using.
Consent Bar